Unveiling the benefts of Vitamin D3 with SGLT-2 inhibitors for hypertensive obese obstructive sleep apnea patients
Background Obstructive sleep apnea (OSA) is associated with poorer quality of life (QoL) and increased cardiovascular risks, which may be exacerbated by hypovitaminosis D. Sodium glucose transporter-2 inhibitor (SGLT2i) provides cardiovascular benefts beyond glycemic control. As vitamin D3 and SGLT...
保存先:
| 主要な著者: | , , , , , , , , , , |
|---|---|
| フォーマット: | 論文 |
| 言語: | English |
| 出版事項: |
BioMed Central Ltd.
2025
|
| 主題: | |
| オンライン･アクセス: | http://ir.unimas.my/id/eprint/47737/1/Unveiling%20the%20benefits.pdf http://ir.unimas.my/id/eprint/47737/ https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-025-06312-w#:~:text=This%20is%20the%20first%20study,QoL%20in%20this%20patient%20population. https://doi.org/10.1186/s12967-025-06312-w |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|
インターネット
http://ir.unimas.my/id/eprint/47737/1/Unveiling%20the%20benefits.pdfhttp://ir.unimas.my/id/eprint/47737/
https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-025-06312-w#:~:text=This%20is%20the%20first%20study,QoL%20in%20this%20patient%20population.
https://doi.org/10.1186/s12967-025-06312-w